搜索
Cyclerion Therapeutics Inc
CYCN添加自选
3.440USD
-0.060-1.71%
收盘 07-31 16:00（美东）报价延迟15分钟
14.59M总市值
亏损市盈率 TTM
关于 Cyclerion Therapeutics Inc 公司
Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering therapies for central nervous system (CNS) diseases. The Company is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. It is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The Company has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.
Cyclerion Therapeutics Inc简介
公司代码CYCN
公司名称Cyclerion Therapeutics Inc
上市日期Mar 18, 2019
CEOGraul (Regina M)
员工数量1
证券类型Ordinary Share
年结日Mar 18
公司地址301 Binney Street
城市CAMBRIDGE
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编02142
电话16176217722
网址https://www.cyclerion.com/
公司代码CYCN
上市日期Mar 18, 2019
CEOGraul (Regina M)
Cyclerion Therapeutics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
910.24K
+38.57%
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
--
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Rhonda M. Chicko
Ms. Rhonda M. Chicko
Chief Financial Officer
Chief Financial Officer
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
910.24K
+38.57%
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
--
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
常见问题
Cyclerion Therapeutics Inc的前五大股东是谁？
Cyclerion Therapeutics Inc 的前五大股东如下：Dr. Peter M. Hecht, Ph.D.
有多少机构持有Cyclerion Therapeutics Inc(CYCN)的股份？
截至2026Q1，共有37家机构持有Cyclerion Therapeutics Inc的股份，合计持有的股份价值约为318.08K，占公司总股份的7.35%。与2025Q4相比，机构持股有所增加，增幅为-667233.00。